Skip to main content

Pharmaceutical Health Outcomes and Policy

Ph.D. Degree Program

The Pharmaceutical Health Outcomes and Policy (PHOP) doctoral degree program at the University of Houston College of Pharmacy offers a learning and research environment that combines the collaborative opportunities of the Texas Medical Center’s world-class healthcare and scientific community with the academic resources and award-winning faculty at Houston’s only Carnegie Institute-designated Tier One public research university.

photo of PHOP students and instructor

Pharmaceutical Health Outcomes and Policy consists of pharmaceutical practice and policy research, a multidisciplinary field that examines cost, access, and quality of pharmaceutical care from clinical, sociobehavioral, economic, organizational and technological perspectives.

Traditional and innovative areas of pharmaceutical health outcomes research include pharmacoepidemiology, pharmacoeconomics, comparative effectiveness research, patient-centered outcomes research, and translational research.

The Ph.D. in Pharmaceutical Health Outcomes and Policy requires the completion of a minimum number of 70 credit hours

Download Ph.D. in Pharmaceutical Health Outcomes and Policy program flier (.pdf)

Download Ph.D. in Pharmaceutical Health Outcomes and Policy program brochure (.pdf)

For additional details about the program, visit the PHOP PhD page here.

For program admissions information, visit the PhD Graduate Admissions page here

Recent PHOP News

Graduate Students Land Internships in Pharmaceutical, Consulting Sectors

PHOP Team Takes Research Competition Trophy at ISPOR International Meeting

4 PHOP Projects Among ISPOR Research Posters Finalists

PHOP Presentations at ISPOR (.pdf)

PHOP Doctoral Candidate Inducted into Phi Kappa Phi Honor Society

Project on COPD Patients in Medicare Gap Strikes Gold at AMCP Meeting

Aparasu Tapped for Fulbright Specialist Roster 

(PDF links requires Adobe Reader; click here for free download.)